Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1999
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334788A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999CA2334545A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2331378A1 Vaccination strategy to prevent and treat cancers
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2329688A1 Cell cycle regulation proteins
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
12/15/1999EP0963998A1 Compositions for treating or preventing prostatic cancer
12/15/1999EP0963988A2 Method of making camptothecin and camptothecin analogs
12/15/1999EP0963986A2 5,10-Dihydrodipyrido(2,3-b:2,3-e)pyrazine and 5,10-dihydro(2,3-b:3,2-e)pyrazine, process for their preparation and pharmaceutical compositions containing them
12/15/1999EP0963440A1 Improved methods for transducing cells
12/15/1999EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999EP0963199A1 Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999EP0750612B1 Acridone-derived bisintercalators as chemotherapeutic agents
12/15/1999EP0743949B1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/15/1999CN1238772A Novel phenanethridinium derivatives
12/15/1999CN1238770A Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/15/1999CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999CN1238755A Asiatic acid derivatives having modified A-ring
12/15/1999CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses
12/15/1999CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999CN1238696A Vaccines
12/15/1999CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/15/1999CN1238689A Vitronectin receptor antagonists
12/15/1999CN1238215A Agent having untitumor activity
12/15/1999CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen
12/15/1999CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/14/1999US6001998 Macrocyclic lactone compounds and their production process
12/14/1999US6001992 Oligonucleotides which promote apoptosis; anticarcinogenic agents, viricides, and treatment of autoimmune disorders
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001965 Human pentapeptide used for testing tumor cells capable of metastases; anticarcinogenic agents; antitumor agents; antiproliferative agents
12/14/1999US6001961 Cyclic adhesion inhibitors
12/14/1999US6001885 Retinoid inhibition of expression of VEGF
12/14/1999US6001882 Photoactivated hypericin and the use thereof
12/14/1999US6001881 Administering to treat arrhythmia, angina pectoris, ischemia, shock, cell proliferation, fibrotic diseases, prostate hyperplasia, fat metabolism disorders, and as a preservative for transplant organs, or to prepare a patient for surgery
12/14/1999US6001855 Thiazole derivatives
12/14/1999US6001839 Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors
12/14/1999US6001651 Antisense modulation of LFA-3
12/14/1999US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production
12/14/1999US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999US6001359 For the detection and treatment of carcinomas derived from the gastrointestinal tract and pancreatic duct
12/14/1999US6001358 Useful for treatment of autoimmune diseases
12/14/1999US6001351 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
12/14/1999US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
12/14/1999CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999CA2186485C An improved method of synthesis for 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione and its dimaleate salt
12/14/1999CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999CA2100258C Acridine derivatives
12/14/1999CA2065150C Inhibitors of thrombin
12/14/1999CA2017767C Anticancer antibiotic mi43-37f11 substance, the production and uses thereof
12/14/1999CA2010636C Substituted pyrroles
12/12/1999CA2274733A1 New derivatives of 5,10-dihydrodipyrido[2,3-b:2,3-e]pyrazine and of 5,10- dihydrodipyrido[2,3-b:3,2-e]pyrazine, their preparation process and pharmaceutical compositions made thereof
12/09/1999WO1999063071A2 Method for triggering apoptosis in cells
12/09/1999WO1999063050A2 Method for preparation and in vivo administration of antigen presenting cell composition
12/09/1999WO1999062944A2 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062909A2 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/09/1999WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999WO1999062890A1 Isothiazole derivatives useful as anticancer agents
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062882A1 Substituted indolinones, the production thereof and their use as medicaments
12/09/1999WO1999062564A1 Radioiodinated phenols for brachytherapy
12/09/1999WO1999062563A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/09/1999WO1999062551A1 Texaphyrin conjugates and uses thereof
12/09/1999WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999WO1999062532A1 Corn extract contraceptive
12/09/1999WO1999062528A1 Treatment of arthritis and other similar conditions
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999062359A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999WO1999054444A3 Combination therapy using nucleic acids and radio therapy
12/09/1999WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof
12/09/1999WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same
12/09/1999WO1999046594A3 C-myc coding region determinant-binding protein (crd-bp)
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999WO1999038528A3 Vaccine formulations
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999DE19824922A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
12/09/1999DE19824811A1 Verfahren zur Auslösung von Apoptose in Zellen Method for triggering of apoptosis in cells
1 ... 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 ... 2211